Abstract
Heterotrimeric G proteins, composed of Gα and Gβγ subunits, transduce extracellular signals via G-protein-coupled receptors to modulate many important intracellular responses. The Gβγ subunits hold a central position in this signaling system and have been implicated in multiple aspects of physiology and the pathophysiology of disease. The Gβ subunit belongs to a large family of WD40 repeat proteins with a circular β-bladed propeller structure. This structure allows Gβγ to interact with a broad range of proteins to play diverse roles. How Gβγ interacts with and regulates such a wide variety of partners yet maintains specificity is an interesting problem in protein-protein molecular recognition in signal transduction, where signal transfer by proteins is often driven by modular conserved recognition motifs. Evidence has accumulated that one mechanism for Gβγ multitarget recognition is through an intrinsically flexible protein surface or “hot spot” that accommodates multiple modes of binding. Because each target has a unique recognition mode for Gβγ subunits, it suggests that these interactions could be selectively manipulated with small molecules, which could have significant therapeutic potential.
Footnotes
This work was supported in part by the National Institutes of Health National Institute of General Medical Sciences [Grant R01-GM081772] (to A.V.S.).
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.111.073072.
-
ABBREVIATIONS:
- GPCR
- G protein-coupled receptor
- GRK
- G protein-coupled receptor kinase
- PLC
- phospholipase C
- GIRK
- G protein-coupled inwardly rectifying potassium channels
- PI3K
- phosphoinositide 3 kinase
- PDB
- Protein Data Bank
- AC
- adenylyl cyclase
- SIGK
- SIGKAFKILGYPDYD
- NCI
- National Cancer Institute
- M119
- 2-(3,4,5-trihydroxy-6-oxoxanthen-9-yl)cyclohexane-1-carboxylic acid
- M201
- N-deacetyl colchicine; 7-amino-1,2,3,10-tetramethoxy-6,7-dihydro-5H-benzo[a]heptalen-9-one.
- Received April 18, 2011.
- Accepted July 6, 2011.
- Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|